Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets
about
Targeting inflammation in diabetes: Newer therapeutic optionsExtracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief ReviewRuscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathyDiabetic kidney disease: from epidemiology to clinical perspectives.New insight into the molecular drug target of diabetic nephropathy.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysisEffects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF RatsDeleterious effects of incense smoke exposure on kidney function and architecture in male albino rats.Effects of a GSK-3β inhibitor on the renal expression levels of RANK, RANKL and NF-κB in a rat model of diabetic nephropathy.Effect of breviscapine injection on clinical parameters in diabetic nephropathy: A meta-analysis of randomized controlled trials.Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and IκB.Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents.Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.New molecular insights in diabetic nephropathy.Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.Anti-Diabetic Agent Sodium Tungstate Induces the Secretion of Pro- and Anti-Inflammatory Cytokines by Human Kidney Cells.Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.Effect of Selenium Supplementation on Glycemic Control and Lipid Profiles in Patients with Diabetic Nephropathy.Involvement of the NF-κB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat modelHaemodialysis in Diabetic Patients Modulates Inflammatory Cytokine Profile and T Cell Activation Status.Salvia miltiorrhiza Lipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2.Long non‑coding RNA BC168687 small interfering RNA reduces high glucose and high free fatty acid‑induced expression of P2X7 receptors in satellite glial cells.Astaxanthin Promotes Nrf2/ARE Signaling to Alleviate Renal Fibronectin and Collagen IV Accumulation in Diabetic Rats.Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase ExpressionCorrelation of vascular endothelial function and coagulation factors with renal function and inflammatory factors in patients with diabetic nephropathy
P2860
Q26852726-FA24401A-3CB8-4A39-A6D7-C2D82BE37A04Q28073215-4A7EC3C4-C1AE-4468-9DF1-2DAC62C54BEBQ31154570-24B05DF7-8674-48C9-8F1D-40A65BF44885Q34042247-18459A41-0A25-4BC4-A8E4-838AE2DF82AFQ34161874-3E0A1250-FE96-4047-B1D9-17B17A865E71Q35125585-9076E7E1-FAB7-41C2-9E9A-23CA96686896Q35145862-48D1F4A0-2AB6-411C-9CCD-D937EC480A0CQ35201598-9BE93DDB-DEA9-47A2-8C9E-A4DDEE2797BAQ35662913-47EEF73F-4D1B-475F-95B7-C90F82A42CEAQ35852316-AA933959-B2E9-4EEA-89C3-CEFF02218165Q36018170-2F89DD01-EA72-41BE-9D8E-31D5DC54241DQ36953281-DB0927CB-650B-45BA-AAB4-0F042412F3B1Q37204321-C0A125AF-A05F-4387-8285-FF57EE12BE26Q37714717-B7FCAF6C-959F-46B1-8045-BAC94559C1EBQ37732016-3FC916C2-5818-41AA-92A7-B41D629BC77CQ38661556-169ECF10-22F2-4EBD-A3AD-5E59284DC143Q38694219-9ADAC7A5-FC37-40F2-BDDF-27F6ABACF26DQ38695966-3733165C-62FD-4FFC-AAAB-4265C60DC107Q38802833-CE9E5284-418C-467B-A08F-990CCEBF3FEBQ38982294-41DAAEAE-C33D-4C4E-885C-24C55DB9A798Q40189595-F646E4EC-21B3-4511-8023-2DD29ACDB5BFQ40485602-1CFDE489-8E1C-45B1-96FC-C32FB90E7E1BQ41235581-200E9512-8E78-4873-B55A-B441C5E88EC2Q46300859-4E7B4D49-0F33-46A8-9B63-5FAE91454815Q50047599-5E37542F-C874-463F-A6C1-18868B70306DQ55128663-38578790-FAC5-4502-A5F4-BDD9CE759C1EQ55424145-5CA5A51D-FCD3-4E13-8356-8AA0A4EB8568Q57491629-690EC657-2A73-411A-8696-3973C56BBE45Q58552449-69886384-24BB-4DE8-B7E0-9FD4CF43604C
P2860
Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inflammation and oxidative str ...... ion as new therapeutic targets
@ast
Inflammation and oxidative str ...... ion as new therapeutic targets
@en
Inflammation and oxidative str ...... ion as new therapeutic targets
@nl
type
label
Inflammation and oxidative str ...... ion as new therapeutic targets
@ast
Inflammation and oxidative str ...... ion as new therapeutic targets
@en
Inflammation and oxidative str ...... ion as new therapeutic targets
@nl
prefLabel
Inflammation and oxidative str ...... ion as new therapeutic targets
@ast
Inflammation and oxidative str ...... ion as new therapeutic targets
@en
Inflammation and oxidative str ...... ion as new therapeutic targets
@nl
P2860
P3181
P356
P1476
Inflammation and oxidative str ...... ion as new therapeutic targets
@en
P2093
Akira Mima
P2860
P304
P3181
P356
10.1155/2013/248563
P407
P577
2013-01-01T00:00:00Z
2013-06-03T00:00:00Z